PREMARIN

LOE Approaching

estrogens, conjugated

NDAORALTABLET
Approved
Jul 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
12

Clinical Trials (5)

NCT01613170Phase 4Unknown

Premarin Versus Toviaz for Treatment of Overactive Bladder

Started Apr 2012
90 enrolled
Overactive Bladder
NCT01436513Phase 1Completed

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

Started Oct 2011
72 enrolled
Primary Ovarian InsufficiencyVaginitisMetrorrhagia+1 more
NCT00745173Phase 1Completed

Study Evaluating Premarin and Bazedoxifene Potential Interaction

Started Sep 2008
30 enrolled
Postmenopause
NCT00706225Phase 1Completed

Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

Started Jun 2008
30 enrolled
Postmenopause
NCT00630435Phase 1Completed

Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation

Started Feb 2008
76 enrolled
Menopause